CIK 0001768446
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832273741
- Phone
- +1 866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,366,820
- in 1 filing, $1.4M under 10b5-1 plans
Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-20 | Pimblett Emily SVP, Finance & CAO | Sale 10b5-1 | −1,242 | $1.24 | $2K | 18,888 |
| 2025-06-18 | Pimblett Emily SVP, Finance & CAO | Option exercise 10b5-1 | +5,000 | 20,130 | ||
| 2025-06-18 | Pimblett Emily SVP, Finance & CAO | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 15,000 | ||
| 2025-03-20 | Pimblett Emily SVP, Finance & CAO | Sale 10b5-1 | −1,199 | $1.31 | $2K | 15,130 |
| 2025-03-18 | Pimblett Emily SVP, Finance & CAO | Option exercise 10b5-1 | +5,000 | 16,329 | ||
| 2025-03-18 | Pimblett Emily SVP, Finance & CAO | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 20,000 | ||
| 2025-01-13 | Pimblett Emily SVP, Finance and CAO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-12-19 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −1,235 | $2.02 | $2K | 11,329 |
| 2024-12-18 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +5,000 | 12,564 | ||
| 2024-12-18 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 25,000 | ||
| 2024-09-20 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −1,182 | $8.18 | $10K | 7,573 |
| 2024-09-20 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9 | $8.06 | $73 | 7,564 |
| 2024-09-18 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +5,000 | 8,755 | ||
| 2024-09-18 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 30,000 | ||
| 2024-06-20 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale | −1,245 | $7.21 | $9K | 3,755 |
| 2024-06-18 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Option exercise | +5,000 | 5,000 | ||
| 2024-06-18 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −5,000 | 35,000 | ||
| 2024-03-18 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | +40,000 | 40,000 |
Page 1 of 1 · 18 trades